Skip to content
OpenCapital
Get started

Tarsus Pharmaceuticals, Inc. TARS Gross margin

Gross margin at other companies

AbbVie logo
AbbVieABBV
70.7%0.0pp
Ocular Therapeutix logo
Ocular TherapeutixOCUL
87.2%-3.4pp
Warby Parker logo
Warby ParkerWRBY
53.4%-1.8pp
Glaukos logo
GlaukosGKOS
78.1%+2.3pp
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
96.1%-2.7pp

Other financials

Income statement

See full
Revenue$162.1M+107%
Gross profit$152.7M+109%
Operating income-$6.1M+76.7%
Net income-$7.0M+72.3%
EPS (diluted)-$0.16+75.0%

Balance sheet

See full
Cash & equivalents$104.2M-41.6%
Total debt$88.7M+22.5%
Total equity$349.0M+1.9%
Total assets$581.1M+16.1%

Cash flow

See full
Operating cash flow-$24.7M-19.4%
CapEx$5.8M+886%
Free cash flow-$30.5M-43.4%

Valuation

See full
Market cap$2.85B+41.1%
Enterprise value$2.83B+47.8%
P/S5.3×-3.3×

Profitability

See full
Operating margin-9.5%-4.2pp
Net margin-9%-4.0pp
FCF margin-28%-12.6pp

Returns & leverage

See full
Return on equity-14%-5.2pp
Debt / equity0.3×0.0×
Current ratio3.7×-1.8×